Expands coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children under nineteen years of age.
Summary
This bill expands New York’s asthma coverage requirements in both Medicaid and private insurance. It amends the Social Services Law to broaden asthma self-management training services for people diagnosed with asthma and for parents of children with asthma, specifically adding instruction on proper use of devices such as spacers, valved holding chambers, and masks, as well as guidance on environmental triggers to avoid or manage. These services must still be ordered by an authorized clinician and provided by a qualified health professional certified as an asthma educator.
The bill also amends multiple sections of the Insurance Law to require coverage for one rescue inhaler and one maintenance inhaler, and to add a second rescue inhaler and second maintenance inhaler for children under 19. In addition, coverage must include medically necessary devices used to administer asthma medication, such as spacers, valved holding chambers, masks, and similar devices. The bill specifies that these coverage requirements cannot be subject to deductibles, copayments, coinsurance, or other cost-sharing requirements, and it applies to policies issued, renewed, altered, or modified on or after the effective date.
Impact
The bill would change state law by expanding mandated asthma-related benefits under Medicaid and private health insurance, including individual, group, and nonprofit health plans covered by the Insurance Law provisions amended here. It creates a new requirement for pediatric asthma coverage and clarifies that associated devices are included when medically necessary. The bill also updates the scope of covered asthma education services in the Social Services Law, while preserving existing licensure and scope-of-practice rules under the Education Law.
Sentiment
The available context suggests generally favorable sentiment toward the bill, as reflected by its framing as a coverage expansion for children with asthma and the absence of recorded opposition, votes, or committee debate in the provided materials. The bill’s sponsor list and the amended text indicate a public-health and affordability rationale, especially by removing cost-sharing for asthma medications and devices. No committee transcript or vote history is provided to show formal disagreement.
Contention
The main policy issue apparent from the text is the cost and administrative burden on insurers and public programs, since the bill requires additional inhaler coverage and device coverage without deductibles or copays. A secondary point is the age-based distinction: the enhanced second inhaler benefit applies only to children under 19, which could prompt questions about why adults are excluded. The bill also conditions the Medicaid-related asthma education expansion on obtaining necessary federal approvals for federal financial participation, indicating a potential implementation hurdle rather than a substantive policy dispute.
Same As
Expands coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children under nineteen years of age.
Expands coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children under nineteen years of age.
Relates to including rescue inhaler prescriptions for asthma and other chronic respiratory diseases for individuals under age nineteen in the statewide immunization information system.
Relates to including rescue inhaler prescriptions for asthma and other chronic respiratory diseases for individuals under age nineteen in the statewide immunization information system.
Enacts "Isabella's law" to require all health insurance policies and medical assistance to provide insurance coverage for the cost of medically necessary hearing aids for children under the age of 16.
Expands Medicaid coverage to include pharmacological treatment for hyperhidrosis when such treatment is ordered by a physician, registered physician assistant, or registered nurse practitioner; provides that the provisions shall not take effect unless all necessary approvals under federal law and regulation have been obtained to receive federal financial participation in the costs.
Expands Medicaid coverage to include pharmacological treatment for hyperhidrosis when such treatment is ordered by a physician, registered physician assistant, or registered nurse practitioner; provides that the provisions shall not take effect unless all necessary approvals under federal law and regulation have been obtained to receive federal financial participation in the costs.
Eliminates the prospective enrollment waiting period for children under the age of nineteen enrolling in the child health insurance plan program by enrolling a child retroactively to the first day of the month in which they are approved for coverage under such program.